ShareValue.ai

ShareValue scores for INGN: Valuation 52, Quality 67, Growth 52, Health 52.

Inogen Inc logo

INGN
NASDAQ

Inogen Inc

$6.54(+0.15%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 16%
Valuation
52
Fair Value
Price vs Value
Quality
67
Moderate
Business Strength
Growth
52
Moderate
Revenue & Earnings
Health
52
Moderate
Financial Stability
Momentum
48
Neutral
Price Trend

Company Details

About

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Score Analysis

AI Investment Thesis

Data as of:Jul 13, 2026
|
Last calculated:Jul 13, 2026